CIRM Funded Clinical Trials

Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury


Jane Lebkowski
Disease Area: 
Investigator:
Institution:
CIRM Grant:
Award Value:
$24,846,856
Trial Sponsor:
Geron Corporation
Trial Stage: 
Phase 1
Trial Status: 
Completed
Targeted Enrollment:
5
ClinicalTrials.gov ID: